Table 4

Clinical outcome at 12-month follow-up

VariablesSurgical group total (n=46)Control group total (n=49)P value
surgical group versus control group
NYHA 1 at 12 months, n (%)35 (85)
Back to professional activity, n/a (%)*27/32 (84)
Total complications 12 months
Mortality, n (%)5 (11)5 (10)0.90
Stroke, n (%)2 (5)0 (0)0.13
Heart failure hospitalisation, n (%)2 (5)2 (5)0.94
New onset AFIB, n/a (%)*2/32 (6)
  • No patients experienced IE, other thromboembolic events or bleedings.

  • *Missing data on nine patients in the surgical group.

  • AFIB, atrial fibrillation; NYHA, New York heart association functional classification; n/a, numbers/available.